All companies
Visit website
NarcX
OperatingNarcX Solutions Inc.
Healthcare · Technology · Founded 2019
Provides a practical, effective and affordable solution to address the problem of drug disposal
Post-money valuation ⓘ
$35.1M
As of May 2022 · from NarcX Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$72,662
Across 1 round since 2021
Latest share price
$1.00
NarcX Common Stock 1 offering price
Financials
FY2019–FY2022 · from SEC filings · hover any figure for its source$77K
−$415K
2019
$235K
−$198K
2020
$92K
−$1.6M
2021
$90K
−$494K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
Income statement
Revenue
$76,948
$235,025
$92,251
$90,272
Cost of goods sold
$69,595
$131,482
$31,931
$33,403
Gross margin
10%
44%
65%
63%
Net income
-$414,530
-$197,772
-$1,559,182
-$494,174
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$126,677
$32,621
-$339
$5,008
Accounts receivable
$0
$0
$2,601
$2,747
Total assets
$126,677
$32,621
$2,870
$38,774
Short-term debt
$4,280
$24,538
$31,511
$25,392
Long-term debt
$417,819
$0
$485,000
$485,000
Total liabilities
$422,099
$24,538
$516,511
$510,392
Other
Headcount
—
5
5
5
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$35.1M
post-money
NarcX Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $72.7K / $1.1MInvestors 66Post-money $35.1M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 2 of 5 annual reports (FY2021–FY2025)
66 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001890401Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.